
Academic Journal
Q2Cellular Signalling
About Cellular Signalling
About Cellular Signalling
Cellular Signalling is a peer-reviewed scholarly journal published by Elsevier B.V. (United States). It focuses on Q2. Publication coverage spans 1989-2026.
Key indicators: ISSN 1873-3913, 0898-6568; H-index 176.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (176): Exceptionally high — 176 articles have each been cited at least 176 times. This indicates deep, sustained influence in the field.
Publishing in Cellular Signalling
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q2. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Cellular Signalling?
1873-3913, 0898-6568.
Who publishes Cellular Signalling?
Elsevier B.V..
What are Cellular Signalling's metrics?
H-index 176.
Is Cellular Signalling peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Protein Kinase Regulation and GTPase Signaling; Receptor Mechanisms and Signaling; Cancer-related molecular mechanisms research; PI3K/AKT/mTOR signaling in cancer; Cell Adhesion Molecules Research; Ubiquitin and proteasome pathways.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
3,550.00 USD; 3,320.00 EUR; 2,840.00 GBP; 440,310.00 JPY
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Reviews
Community Reviews
Version History
October 9, 2026 at 7:50 pm
September 25, 2026